Search

Mark L. Berch

Examiner (ID: 99)

Most Active Art Unit
1202
Art Unit(s)
1202, 1624, 1622, 1802, 2899, 1614, 1611
Total Applications
3573
Issued Applications
2301
Pending Applications
170
Abandoned Applications
1103

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5136469 [patent_doc_number] => 20070078098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Anti-hypercholesterolemic compounds' [patent_app_type] => utility [patent_app_number] => 11/542966 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13039 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078098.pdf [firstpage_image] =>[orig_patent_app_number] => 11542966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/542966
Anti-hypercholesterolemic compounds Oct 3, 2006 Issued
Array ( [id] => 4971993 [patent_doc_number] => 20070111996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Pyrazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 11/537002 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35783 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 59 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111996.pdf [firstpage_image] =>[orig_patent_app_number] => 11537002 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/537002
Pyrazolopyrimidines and related analogs as HSP90-inhibitors Sep 28, 2006 Abandoned
Array ( [id] => 4971994 [patent_doc_number] => 20070111997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Triazolopyrimidines and related analogs as HSP90-inhibitors' [patent_app_type] => utility [patent_app_number] => 11/537017 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25431 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111997.pdf [firstpage_image] =>[orig_patent_app_number] => 11537017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/537017
Triazolopyrimidines and related analogs as HSP90-inhibitors Sep 28, 2006 Abandoned
Array ( [id] => 5564693 [patent_doc_number] => 20090137546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Anti-Hypercholesterolemic Compounds' [patent_app_type] => utility [patent_app_number] => 11/992990 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137546.pdf [firstpage_image] =>[orig_patent_app_number] => 11992990 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992990
Anti-Hypercholesterolemic Compounds Sep 28, 2006 Abandoned
Array ( [id] => 5285541 [patent_doc_number] => 20090099216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067781 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18415 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099216.pdf [firstpage_image] =>[orig_patent_app_number] => 12067781 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067781
NOVEL ADENINE COMPOUND Sep 21, 2006 Abandoned
Array ( [id] => 5586010 [patent_doc_number] => 20090105212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067651 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31215 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105212.pdf [firstpage_image] =>[orig_patent_app_number] => 12067651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067651
NOVEL ADENINE COMPOUND Sep 21, 2006 Abandoned
Array ( [id] => 5290993 [patent_doc_number] => 20090023723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Purinone derivatives for treating neurodegenerative diseases' [patent_app_type] => utility [patent_app_number] => 11/534096 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17867 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023723.pdf [firstpage_image] =>[orig_patent_app_number] => 11534096 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/534096
Purinone derivatives for treating neurodegenerative diseases Sep 20, 2006 Abandoned
Array ( [id] => 5380314 [patent_doc_number] => 20090192153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'NOVEL ADENINE COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/067780 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35427 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192153.pdf [firstpage_image] =>[orig_patent_app_number] => 12067780 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067780
NOVEL ADENINE COMPOUND Sep 20, 2006 Abandoned
Array ( [id] => 4860390 [patent_doc_number] => 20080269240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Novel Adenine Compound' [patent_app_type] => utility [patent_app_number] => 12/067446 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47900 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269240.pdf [firstpage_image] =>[orig_patent_app_number] => 12067446 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067446
Novel Adenine Compound Sep 20, 2006 Abandoned
Array ( [id] => 5265578 [patent_doc_number] => 20090118263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Novel Adenine Compound' [patent_app_type] => utility [patent_app_number] => 12/067649 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39505 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118263.pdf [firstpage_image] =>[orig_patent_app_number] => 12067649 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067649
Novel Adenine Compound Sep 19, 2006 Abandoned
Array ( [id] => 5509125 [patent_doc_number] => 20090082332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS' [patent_app_type] => utility [patent_app_number] => 12/067536 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16395 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082332.pdf [firstpage_image] =>[orig_patent_app_number] => 12067536 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/067536
PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL OR ALLERGIC DISEASES AND CANCERS Sep 19, 2006 Abandoned
Array ( [id] => 7693769 [patent_doc_number] => 20070015917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Method For Manufacture of Ceftriaxone Sodium' [patent_app_type] => utility [patent_app_number] => 11/532485 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15214 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015917.pdf [firstpage_image] =>[orig_patent_app_number] => 11532485 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532485
Method For Manufacture of Ceftriaxone Sodium Sep 14, 2006 Abandoned
Array ( [id] => 560719 [patent_doc_number] => 07470786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Method for manufacture of ceftriaxone sodium' [patent_app_type] => utility [patent_app_number] => 11/532469 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15004 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470786.pdf [firstpage_image] =>[orig_patent_app_number] => 11532469 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/532469
Method for manufacture of ceftriaxone sodium Sep 14, 2006 Issued
Array ( [id] => 5496615 [patent_doc_number] => 20090264643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Process for The Preparation of Beta-Lactam Antibiotic' [patent_app_type] => utility [patent_app_number] => 11/991624 [patent_app_country] => US [patent_app_date] => 2006-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5088 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264643.pdf [firstpage_image] =>[orig_patent_app_number] => 11991624 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/991624
Process for the preparation of beta-lactam antibiotic meropenem trihydrate Sep 14, 2006 Issued
Array ( [id] => 5101802 [patent_doc_number] => 20070185064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => '2-Aminopurine Analogs Having HSP90-Inhibiting Activity' [patent_app_type] => utility [patent_app_number] => 11/531221 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48111 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185064.pdf [firstpage_image] =>[orig_patent_app_number] => 11531221 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/531221
2-Aminopurine Analogs Having HSP90-Inhibiting Activity Sep 11, 2006 Abandoned
Array ( [id] => 4705181 [patent_doc_number] => 20080064705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation' [patent_app_type] => utility [patent_app_number] => 11/520174 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6913 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064705.pdf [firstpage_image] =>[orig_patent_app_number] => 11520174 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/520174
Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation Sep 11, 2006 Abandoned
Array ( [id] => 5576038 [patent_doc_number] => 20090143400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/066952 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10292 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143400.pdf [firstpage_image] =>[orig_patent_app_number] => 12066952 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066952
PURINE DERIVATIVES HAVING IMMUNO-MODULATING PROPERTIES Sep 11, 2006 Abandoned
Array ( [id] => 5160439 [patent_doc_number] => 20070173483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/531218 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46442 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173483.pdf [firstpage_image] =>[orig_patent_app_number] => 11531218 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/531218
Pyrrolopyrimidines and Related Analogs as HSP90-Inhibitors Sep 11, 2006 Abandoned
Array ( [id] => 5016636 [patent_doc_number] => 20070259845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe' [patent_app_type] => utility [patent_app_number] => 11/517704 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10223 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259845.pdf [firstpage_image] =>[orig_patent_app_number] => 11517704 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/517704
Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe Sep 7, 2006 Abandoned
Array ( [id] => 5063664 [patent_doc_number] => 20070225304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 11/470347 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8552 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225304.pdf [firstpage_image] =>[orig_patent_app_number] => 11470347 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/470347
AMINOPURINE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES Sep 5, 2006 Abandoned
Menu